Senior insider sale
SVP, Comm & Medical Affairs at THERAVANCE BIOPHARMA, INC. — senior position signals high conviction
$582.5K
31.07K shares
What this filing means
FARNUM RHONDA plans to sell 31.07K shares of THERAVANCE BIOPHARMA, INC. valued at approximately $582.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/3/2025ACC: 0001950047-25-009691
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
31.07K
Shares to sell
$582.5K
Approx. market value
31.07K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Restricted Stock
Not Applicable
8/20/2025
9.03KRestricted Stock
Not Applicable
5/20/2023
8.74KRestricted Stock
Not Applicable
11/20/2022
11.60KRestricted Stock
Not Applicable
8/20/2021
1.70KTotal acquired31.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/20/2025 | Restricted Stock Not Applicable | 9.03K | — |
5/20/2023 | Restricted Stock Not Applicable | 8.74K | — |
11/20/2022 | Restricted Stock Not Applicable | 11.60K | — |
8/20/2021 | Restricted Stock Not Applicable | 1.70K | — |
| Total | 31.07K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
31.07K
Market value
$582.5K
12/3/2025
Total
Units
31.07K
Value
$582.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/3/2025 | 31.07K | $582.5K | NASDAQ | Planned |
| Total | 31.07K | $582.5K | ||